Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Synovial Sarcoma Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Synovial Sarcoma Treatment Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Synovial Sarcoma Treatment Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Type
    • 1.4.2 ACXT-3102
    • 1.4.3 AL-3818
    • 1.4.4 Axitinib
    • 1.4.5 CMB-305
    • 1.4.6 CUE-102
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Synovial Sarcoma Treatment Market Size, Estimates and Forecasts
    • 2.1.1 Global Synovial Sarcoma Treatment Revenue 2015-2026
    • 2.1.2 Global Synovial Sarcoma Treatment Sales 2015-2026
  • 2.2 Global Synovial Sarcoma Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Synovial Sarcoma Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Synovial Sarcoma Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Synovial Sarcoma Treatment Competitor Landscape by Players

  • 3.1 Synovial Sarcoma Treatment Sales by Manufacturers
    • 3.1.1 Synovial Sarcoma Treatment Sales by Manufacturers (2015-2020)
    • 3.1.2 Synovial Sarcoma Treatment Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Synovial Sarcoma Treatment Revenue by Manufacturers
    • 3.2.1 Synovial Sarcoma Treatment Revenue by Manufacturers (2015-2020)
    • 3.2.2 Synovial Sarcoma Treatment Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Synovial Sarcoma Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Synovial Sarcoma Treatment Revenue in 2019
    • 3.2.5 Global Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Synovial Sarcoma Treatment Price by Manufacturers
  • 3.4 Synovial Sarcoma Treatment Manufacturing Base Distribution, Product Types
    • 3.4.1 Synovial Sarcoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Synovial Sarcoma Treatment Product Type
    • 3.4.3 Date of International Manufacturers Enter into Synovial Sarcoma Treatment Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Synovial Sarcoma Treatment Market Size by Type (2015-2020)
    • 4.1.1 Global Synovial Sarcoma Treatment Sales by Type (2015-2020)
    • 4.1.2 Global Synovial Sarcoma Treatment Revenue by Type (2015-2020)
    • 4.1.3 Synovial Sarcoma Treatment Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Synovial Sarcoma Treatment Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Synovial Sarcoma Treatment Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Synovial Sarcoma Treatment Revenue Forecast by Type (2021-2026)
    • 4.2.3 Synovial Sarcoma Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Synovial Sarcoma Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Synovial Sarcoma Treatment Market Size by Application (2015-2020)
    • 5.1.1 Global Synovial Sarcoma Treatment Sales by Application (2015-2020)
    • 5.1.2 Global Synovial Sarcoma Treatment Revenue by Application (2015-2020)
    • 5.1.3 Synovial Sarcoma Treatment Price by Application (2015-2020)
  • 5.2 Synovial Sarcoma Treatment Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Synovial Sarcoma Treatment Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Synovial Sarcoma Treatment Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Synovial Sarcoma Treatment Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Synovial Sarcoma Treatment by Country
    • 6.1.1 North America Synovial Sarcoma Treatment Sales by Country
    • 6.1.2 North America Synovial Sarcoma Treatment Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Synovial Sarcoma Treatment Market Facts & Figures by Type
  • 6.3 North America Synovial Sarcoma Treatment Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Synovial Sarcoma Treatment by Country
    • 7.1.1 Europe Synovial Sarcoma Treatment Sales by Country
    • 7.1.2 Europe Synovial Sarcoma Treatment Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Synovial Sarcoma Treatment Market Facts & Figures by Type
  • 7.3 Europe Synovial Sarcoma Treatment Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Synovial Sarcoma Treatment by Region
    • 8.1.1 Asia Pacific Synovial Sarcoma Treatment Sales by Region
    • 8.1.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Synovial Sarcoma Treatment Market Facts & Figures by Type
  • 8.3 Asia Pacific Synovial Sarcoma Treatment Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Synovial Sarcoma Treatment by Country
    • 9.1.1 Latin America Synovial Sarcoma Treatment Sales by Country
    • 9.1.2 Latin America Synovial Sarcoma Treatment Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Synovial Sarcoma Treatment Market Facts & Figures by Type
  • 9.3 Central & South America Synovial Sarcoma Treatment Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Synovial Sarcoma Treatment by Country
    • 10.1.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Country
    • 10.1.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Synovial Sarcoma Treatment Market Facts & Figures by Type
  • 10.3 Middle East and Africa Synovial Sarcoma Treatment Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Adaptimmune Therapeutics Plc
    • 11.1.1 Adaptimmune Therapeutics Plc Corporation Information
    • 11.1.2 Adaptimmune Therapeutics Plc Description and Business Overview
    • 11.1.3 Adaptimmune Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Products Offered
    • 11.1.5 Adaptimmune Therapeutics Plc Related Developments
  • 11.2 Advenchen Laboratories LLC
    • 11.2.1 Advenchen Laboratories LLC Corporation Information
    • 11.2.2 Advenchen Laboratories LLC Description and Business Overview
    • 11.2.3 Advenchen Laboratories LLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Advenchen Laboratories LLC Synovial Sarcoma Treatment Products Offered
    • 11.2.5 Advenchen Laboratories LLC Related Developments
  • 11.3 EpiZyme Inc
    • 11.3.1 EpiZyme Inc Corporation Information
    • 11.3.2 EpiZyme Inc Description and Business Overview
    • 11.3.3 EpiZyme Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 EpiZyme Inc Synovial Sarcoma Treatment Products Offered
    • 11.3.5 EpiZyme Inc Related Developments
  • 11.4 Immune Design Corp
    • 11.4.1 Immune Design Corp Corporation Information
    • 11.4.2 Immune Design Corp Description and Business Overview
    • 11.4.3 Immune Design Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Immune Design Corp Synovial Sarcoma Treatment Products Offered
    • 11.4.5 Immune Design Corp Related Developments
  • 11.5 Immunocore Ltd
    • 11.5.1 Immunocore Ltd Corporation Information
    • 11.5.2 Immunocore Ltd Description and Business Overview
    • 11.5.3 Immunocore Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Immunocore Ltd Synovial Sarcoma Treatment Products Offered
    • 11.5.5 Immunocore Ltd Related Developments
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Corporation Information
    • 11.6.2 Johnson & Johnson Description and Business Overview
    • 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Johnson & Johnson Synovial Sarcoma Treatment Products Offered
    • 11.6.5 Johnson & Johnson Related Developments
  • 11.7 Karyopharm Therapeutics Inc
    • 11.7.1 Karyopharm Therapeutics Inc Corporation Information
    • 11.7.2 Karyopharm Therapeutics Inc Description and Business Overview
    • 11.7.3 Karyopharm Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Products Offered
    • 11.7.5 Karyopharm Therapeutics Inc Related Developments
  • 11.8 Merck & Co Inc
    • 11.8.1 Merck & Co Inc Corporation Information
    • 11.8.2 Merck & Co Inc Description and Business Overview
    • 11.8.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merck & Co Inc Synovial Sarcoma Treatment Products Offered
    • 11.8.5 Merck & Co Inc Related Developments
  • 11.9 Millennium Pharmaceuticals Inc
    • 11.9.1 Millennium Pharmaceuticals Inc Corporation Information
    • 11.9.2 Millennium Pharmaceuticals Inc Description and Business Overview
    • 11.9.3 Millennium Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Products Offered
    • 11.9.5 Millennium Pharmaceuticals Inc Related Developments
  • 11.10 Novartis AG
    • 11.10.1 Novartis AG Corporation Information
    • 11.10.2 Novartis AG Description and Business Overview
    • 11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Novartis AG Synovial Sarcoma Treatment Products Offered
    • 11.10.5 Novartis AG Related Developments
  • 11.1 Adaptimmune Therapeutics Plc
    • 11.1.1 Adaptimmune Therapeutics Plc Corporation Information
    • 11.1.2 Adaptimmune Therapeutics Plc Description and Business Overview
    • 11.1.3 Adaptimmune Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Products Offered
    • 11.1.5 Adaptimmune Therapeutics Plc Related Developments
  • 11.12 Takara Bio Inc
    • 11.12.1 Takara Bio Inc Corporation Information
    • 11.12.2 Takara Bio Inc Description and Business Overview
    • 11.12.3 Takara Bio Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Takara Bio Inc Products Offered
    • 11.12.5 Takara Bio Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Synovial Sarcoma Treatment Market Estimates and Projections by Region
    • 12.1.1 Global Synovial Sarcoma Treatment Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Synovial Sarcoma Treatment Revenue Forecast by Regions 2021-2026
  • 12.2 North America Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
    • 12.2.1 North America: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
    • 12.2.2 North America: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
    • 12.2.3 North America: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
    • 12.3.2 Europe: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Synovial Sarcoma Treatment Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Synovial Sarcoma Treatment Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Synovial Sarcoma Treatment Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Synovial Sarcoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Synovial Sarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Synovial Sarcoma Treatment market is segmented into
    ACXT-3102
    AL-3818
    Axitinib
    CMB-305
    CUE-102
    Others

    Segment by Application, the Synovial Sarcoma Treatment market is segmented into
    Hospital
    Clinic
    Others

    Regional and Country-level Analysis
    The Synovial Sarcoma Treatment market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Synovial Sarcoma Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Synovial Sarcoma Treatment Market Share Analysis
    Synovial Sarcoma Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Synovial Sarcoma Treatment business, the date to enter into the Synovial Sarcoma Treatment market, Synovial Sarcoma Treatment product introduction, recent developments, etc.

    The major vendors covered:
    Adaptimmune Therapeutics Plc
    Advenchen Laboratories LLC
    EpiZyme Inc
    Immune Design Corp
    Immunocore Ltd
    Johnson & Johnson
    Karyopharm Therapeutics Inc
    Merck & Co Inc
    Millennium Pharmaceuticals Inc
    Novartis AG
    Pfizer Inc
    Takara Bio Inc

    Buy now